Arvinas Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
/ 
Frequently asked questions
To buy Arvinas Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Arvinas Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Arvinas Inc. is ARVN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Arvinas Inc. has its primary listing on NASDAQ. You can trade Arvinas Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Arvinas Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Arvinas Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Arvinas Inc..